发明名称 2-amino-3-(alkyl)-pyrimidone derivatives as GSK3.beta.inhibitors
摘要 A pyrimidone derivative represented by formula (I) or a salt thereof:Wherein:R1 represents a hydrogen atom or a C1-6 alkyl group which may be substituted by a C6,10 aryl group;R2 represents a C1-10 alkyl group which may be substituted, a C2-6 alkenyl group which may be substituted, a C3-6 alkynyl group which may be substituted, a C3-6 cycloalkyl group which may be substituted, or a C6-10 ARYL group which may be substituted;or R1 and R2 form together a C2-6 alkylene group which may be substituted;or R1 and R2 form together a chain of formula -(CH2)2-X-(CH2)2- or -(CH2)2-X-(CH2)3- where X represents a oxygen atom, a sulfur atom, or a nitrogen atom which may be substituted;R3 represents a 2, 3 or 4-pyridyl group optionally substituted by a C1-4 alkyl group, C1-4 alkoxy group or halogen atom; andR4 represents a C1-10 alkyl group optionally substituted by a hydroxyl group, amino, C1-6 monoalkylamino group, C2-12 dialkylamino group or C6,10 aryl group which may be substituted.And a medicament comprising the said derivative or a salt thereof as an active ingredient which is used for preventive and/or therapeutic treatment of a neurodegenerative disease caused by abnormal activity of GSK3beta such as Alzheimer's disease.
申请公布号 US6844335(B2) 申请公布日期 2005.01.18
申请号 US20020221598 申请日期 2002.12.02
申请人 SANOFI-SYNTHELABO;MITSUBISHI PHARMA CORPORATION 发明人 ALMARIO GARCIA ANTONIO;ANDO RYOICHI;ARIMOTO KEIICHI;UEHARA FUMIAKI;LI ADRIEN TAK;SHODA AYA;FROST JONATHAN REID;WATANABE KAZUTOSHI
分类号 A61K31/505;A61K31/506;A61P3/04;A61P3/10;A61P5/00;A61P9/00;A61P11/00;A61P15/00;A61P17/02;A61P17/14;A61P19/00;A61P25/00;A61P25/02;A61P25/18;A61P25/24;A61P25/26;A61P25/28;A61P27/02;A61P27/06;A61P31/12;A61P35/00;A61P35/02;A61P43/00;C07D401/04;C07D401/14;C07D409/14;(IPC1-7):C07D401/04 主分类号 A61K31/505
代理机构 代理人
主权项
地址